Biohaven Ltd.

Healthcare

NYSE:BHVN · New York Stock Exchange

Market Cap $1.42B Beta 3.31 P/E (TTM) -3.1

$13.57 -1.62%

-$0.22 today

52W Low $7.48High $18.57

Vol 6.46M · Avg 2.47M

EPS (TTM) -$4.39Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-6.15%

Period High

$18.11

Period Low

$7.79

Latest

$13.57

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Vera Therapeutics, Inc.

NASDAQ:VERA

$2.51B

Pharvaris N.V.

NASDAQ:PHVS

$2.28B

Celldex Therapeutics, Inc.

NASDAQ:CLDX

$2.20B

Immunome, Inc.

NASDAQ:IMNM

$1.73B

Intellia Therapeutics, Inc.

NASDAQ:NTLA

$1.69B

Sionna Therapeutics, Inc.

NASDAQ:SION

$1.68B

AbCellera Biologics Inc.

NASDAQ:ABCL

$1.65B

Immunocore Holdings plc

NASDAQ:IMCR

$1.46B

Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

$1.20B

Zenas BioPharma, Inc.

NASDAQ:ZBIO

$857.47M

What is the latest BHVN filing?

The latest filing shown is 8-K dated May 27, 2026.

How many recent filings does BHVN have?

Intrinsic Alpha currently shows 20 recent filings for BHVN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.